7
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Drug Evaluation Central & Peripheral Nervous Systems: Tiagabine: current status and potential clinical applications

Pages 1377-1387 | Published online: 03 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Steven C Schachter. (2001) Pharmacology and clinical experience with tiagabine. Expert Opinion on Pharmacotherapy 2:1, pages 179-187.
Read now

Articles from other publishers (10)

Ruben Vardanyan. 2017. Piperidine-Based Drug Discovery. Piperidine-Based Drug Discovery 127 146 .
Rajiv P. Sharma, Brian Martis, John M. Davis, Russell Omens & Philip G. Janicak. (2001) Tiagabine, a Specific γ-Aminobutyric Acid Transporter-1 Inhibitor, in the Treatment of Psychosis. Journal of Clinical Psychopharmacology 21:3, pages 347-349.
Crossref
Steven C. Schachter. (2001) Epilepsy. Neurologic Clinics 19:1, pages 57-78.
Crossref
D Schmidt, L Gram, M Brodie, G Krämer, E Perucca, R Kälviäinen & C.E Elger. (2000) Tiagabine in the treatment of epilepsy — a clinical review with a guide for the prescribing physician. Epilepsy Research 41:3, pages 245-251.
Crossref
Paul E KeckJrJr, Susan L McElroy & Jerry A Bennett. (2001) Pharmacologic loading in the treatment of acute mania. Bipolar Disorders 2:1, pages 42-46.
Crossref
Steven C. Schachter. (1999) Antiepileptic Drug Therapy: General Treatment Principles and Application for Special Patient Populations. Epilepsia 40:s9, pages S20-S25.
Crossref
Steven C. Schachter. (1999) Tiagabine. Epilepsia 40:s5, pages s17-s22.
Crossref
S. C. Schachter. 1999. Antiepileptic Drugs. Antiepileptic Drugs 447 463 .
Mikael Søndergård Thomsen, Lisbet Groes, Henrik Agersø & Trine Kruse. (2013) Lack of Pharmacokinetic Interaction between Tiagabine and Erythromycin. The Journal of Clinical Pharmacology 38:11, pages 1051-1056.
Crossref
Nils Ole Dalby & Erik B Nielsen. (1997) Tiagabine exerts an anti-epileptogenic effect in amygdala kindling epileptogenesis in the rat. Neuroscience Letters 229:2, pages 135-137.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.